Physician profile
Eddie Yang
NPI 1235166794
$1,873.86
in general payments reported to CMS, 2019-2025
12 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $550 · 2020: $191 · 2021: $209 · 2022: $261 · 2023: $308 · 2024: $180 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $783.98 | 2019-2025 | Bexsero, Pediarix, Penmenvy |
| Pfizer INC. | $407.59 | 2019-2022 | |
| Kaleo, INC. | $126.25 | 2022-2024 | Auvi-Q |
| Gilead Sciences, INC. | $125.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $90.00 | 2019 | |
| Caris Mpi, INC. | $84.76 | 2025 | Mi Cancer Seek |
| Kowa Pharmaceuticals America, INC. | $50.21 | 2025 | Zoryve |
| Merck Sharp & Dohme LLC | $48.54 | 2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Phadia US INC. | $21.04 | 2021 | |
| Sanofi Pasteur INC. | $19.05 | 2022 | |
| Seqirus USA INC | $17.44 | 2025 | Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eddie Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.